Cortexyme Inc.

💊 Neuropharmaceuticals· 📍 San Francisco, CA, USA

Overview

Cortexyme develops small-molecule therapeutics targeting bacterial pathogens linked to Alzheimer's disease neuroinflammation and neurodegeneration.

Neuralstem Inc.

Germantown, MD, USA

Neurogenix Therapeutics

Basel, Switzerland

Acadia Pharmaceuticals

San Diego, USA

Acer Therapeutics

Newton, MA, USA

Praxis Precision Medicine

Cambridge, MA, USA

Axsome Therapeutics

New York, USA

University of Michigan Completes First Long-Term Wireless Brain-Computer Interface Implant in Humans

2026-07-07 · Research

Synchron Closes $275M Series E to Accelerate Stentrode BCI Commercialization

2026-06-29 · Funding

Precision Neuroscience Closes $120M Series D to Accelerate Cortical Array Commercialization

2026-06-24 · Funding

It's Finally Here: FacialDx, an AI-Powered Support Tool for Sideline Concussion Assessments

2026-06-23 · Product

Claim this listing to add your logo, full description, team, and products. Premium listings get featured placement.

Advertise

Newsletter sponsorships, featured listings, and sponsored articles.